Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Zic4 Antibody Positive Autoimmune Encephalitis Responding to Rituximab After Failing First Line Therapies: A Case Report
Autoimmune Neurology
P11 - Poster Session 11 (8:00 AM-9:00 AM)
15-007
NA

We present a 67 year old man admitted with progressive generalized weakness and altered mental status, found to have autoimmune encephalitis after his CSF tested positive for a rare onconeural antibody Zic4. Patients with Zic4 antibodies have been found to present with a cerebellar syndrome which correlated with his MRI brain findings of generalized atrophy, most prominent in the cerebellum, that were not present on previous scans. The malignancy survey was negative in his case. He failed multiple first line therapies including intravenous immunoglobulin (IVIG) and plasmapheresis with subsequent minimal neurocognitive response to intravenous steroids.  However, he responded to Rituximab with significant improvement in cognition but limited improvement in motor skills thus far. We also explore the possible association with recent epidural platelet rich plasma (PRP) therapy treatment.

NA
NA
NA
Authors/Disclosures
Mays Alani, MD (AdventHealth Medical Group Neurology at Deland)
PRESENTER
No disclosure on file
Fabian H. Rossi, MD Dr. Rossi has nothing to disclose.
Michael Hoffmann, MD, FCP, FAHA, FÂé¶¹´«Ã½Ó³»­ No disclosure on file
Lourdes Benes, MD, FÂé¶¹´«Ã½Ó³»­ (Neurology One) Dr. Benes has nothing to disclose.
Umesh K. Sharma, MD (Orlando VA Medical Center) Dr. Sharma has nothing to disclose.
Nina Tsakadze, MD, PhD (Restorative Neurology and Headache Center LLC) No disclosure on file